FT-827

CAS No. 1959537-86-0

FT-827 ( FT827;FT 827 )

Catalog No. M13071 CAS No. 1959537-86-0

A novel potent, specific, covalent USP7 inhibitor with Kd of 7.8 uM (USP7 catalytic domain).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    FT-827
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel potent, specific, covalent USP7 inhibitor with Kd of 7.8 uM (USP7 catalytic domain).
  • Description
    A novel potent, specific, covalent USP7 inhibitor with Kd of 7.8 uM (USP7 catalytic domain); modifies the catalytic Cys223 of USP7 and inhibits the enzyme with kinact/Ki of 66 M-1s-1, display good USP7 selectivity in a panel of 38 deubiquitinases (DUBs)
  • Synonyms
    FT827;FT 827
  • Pathway
    Proteasome/Ubiquitin
  • Target
    DUB
  • Recptor
    DUB
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1959537-86-0
  • Formula Weight
    548.62
  • Molecular Formula
    C27H28N6O5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 125 mg/mL 227.85 mM
  • SMILES
    O=C(N1CCC(O)(CN2C=NC(N(C)N=C3)=C3C2=O)CC1)C(C=C4)=CC=C4C5=CC=CC=C5NS(C=C)(=O)=O
  • Chemical Name
    N-(4'-(4-hydroxy-4-((1-methyl-4-oxo-1,4-dihydro-5H-pyrazolo[3,4-d]pyrimidin-5-yl)methyl)piperidine-1-carbonyl)-[1,1'-biphenyl]-2-yl)ethenesulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Turnbull AP, et al. Nature. 2017 Oct 26;550(7677):481-486.
molnova catalog
related products
  • USP8-IN-22e

    A potent, selective ubiquitin-specific protease USP8 inhibitor with IC50 of 0.28 uM.

  • MK8745

    MK-8745 is a potent and selective Aurora A inhibitor.

  • FT-671

    FT-671 is a novel potent, specific, non-covalent USP7 inhibitor with Kd of 65 nM (USP7 catalytic domain).